Chemoinformaics analysis of 2-PENTYL-5-PROPYLRESORCINOL
| Molecular Weight | 222.328 | nRot | 6 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 6 |
| Exact Molecular Weight | 222.162 | nRing | 1 |
| Solubility: LogS | -3.448 | nHRing | 0 |
| Solubility: LogP | 5.111 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 39.6534 |
| nHD | 2 | BPOL | 22.0706 |
| QED | 0.719 |
| Synth | 2.174 |
| Natural Product Likeliness | 0.767 |
| NR-PPAR-gamma | 0.958 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.156 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.767 |
| MDCK | 0.0000207 |
| BBB | 0.31 |
| PPB | 0.971995 |
| VDSS | 2.627 |
| FU | 0.0266306 |
| CYP1A2-inh | 0.963 |
| CYP1A2-sub | 0.868 |
| CYP2c19-inh | 0.844 |
| CYP2c19-sub | 0.233 |
| CYP2c9-inh | 0.523 |
| CYP2c9-sub | 0.948 |
| CYP2d6-inh | 0.87 |
| CYP2d6-sub | 0.873 |
| CYP3a4-inh | 0.207 |
| CYP3a4-sub | 0.147 |
| CL | 9.609 |
| T12 | 0.711 |
| hERG | 0.031 |
| Ames | 0.169 |
| ROA | 0.153 |
| SkinSen | 0.939 |
| Carcinogencity | 0.034 |
| EI | 0.965 |
| Respiratory | 0.357 |
| NR-Aromatase | 0.645 |
| Antiviral | Yes |
| Prediction | 0.817113 |